Cargando…
Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer
The clinical parameters and the histological and immunohistochemical findings of a prospective protocolized series of 27 prostate carcinoma patients with oligometastatic disease followed homogeneously were analyzed. Lymph nodes (81.5%) and bones (18.5%) were the only metastatic sites. Local control...
Autores principales: | Manini, Claudia, González, Alba, Büchser, David, García-Olaverri, Jorge, Urresola, Arantza, Ezquerro, Ana, Fernández, Iratxe, Llarena, Roberto, Zabalza, Iñaki, Pulido, Rafael, Carracedo, Arkaitz, Gómez-Iturriaga, Alfonso, López, José I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761807/ https://www.ncbi.nlm.nih.gov/pubmed/33291528 http://dx.doi.org/10.3390/jpm10040265 |
Ejemplares similares
-
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
por: Buchser, David, et al.
Publicado: (2016) -
MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
por: Gomez-Iturriaga, A., et al.
Publicado: (2020) -
Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016) -
Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy
por: Gomez-Iturriaga, Alfonso, et al.
Publicado: (2014) -
Role of surgery in oligometastatic prostate cancer
por: Jenjitranant, Pocharapong, et al.
Publicado: (2019)